The Chemours Company
General ticker "CC" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $2.4B (TTM average)
The Chemours Company follows the US Stock Market performance with the rate: 30.5%.
Estimated limits based on current volatility of 1.7%: low 15.22$, high 15.83$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-08-14, amount 0.09$ (Y2.30%)
- Total employees count: 5700 (-5.0%) as of 2025
- North America accounted for 44.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Litigation risks, Regulatory and compliance, Geopolitical risks, Cybersecurity threats, Climate change and natural disasters
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [7.58$, 15.50$]
- 2026-12-31 to 2027-12-31 estimated range: [8.47$, 16.75$]
Financial Metrics affecting the CC estimates:
- Positive: with PPE of 12.4 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 14.74 > 13.08
- Positive: -4.23 < Operating profit margin, % of -0.09
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of 5.08 <= 5.56
- Negative: Interest expense per share per price, % of 15.02 > 3.34
- Positive: Shareholder equity ratio, % of 3.39 <= 18.97
- Positive: -9.15 < Industry operating profit margin (median), % of 1.52
Short-term CC quotes
Long-term CC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $6,005.00MM | $5,782.00MM | $5,808.00MM |
| Operating Expenses | $6,323.00MM | $5,339.00MM | $5,813.00MM |
| Operating Income | $-318.00MM | $443.00MM | $-5.00MM |
| Non-Operating Income | $0.00MM | $-316.00MM | $-272.00MM |
| Interest Expense | $208.00MM | $264.00MM | $269.00MM |
| R&D Expense | $108.00MM | $109.00MM | $108.00MM |
| Income(Loss) | $-318.00MM | $127.00MM | $-277.00MM |
| Taxes | $-81.00MM | $41.00MM | $109.00MM |
| Net Income(Loss)* | $-253.00MM | $86.00MM | $-386.00MM |
| Stockholders Equity | $737.00MM | $571.00MM | $250.00MM |
| Inventory | $1,352.00MM | $1,472.00MM | $1,569.00MM |
| Assets | $8,251.00MM | $7,509.00MM | $7,382.00MM |
| Operating Cash Flow | $556.00MM | $-633.00MM | $264.00MM |
| Capital expenditure | $370.00MM | $360.00MM | $213.00MM |
| Investing Cash Flow | $-229.00MM | $-353.00MM | $-206.00MM |
| Financing Cash Flow | $172.00MM | $-36.00MM | $-126.00MM |
| Earnings Per Share** | $-1.70 | $0.58 | $-2.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.